26Oct

EKF launches PrimeStore® MTM pathogenic sample collection and transportation kit

Cardiff, UK – 26th October 2020 – EKF Diagnostics, the global in vitro diagnostics company, announces that it has launched a PrimeStore® MTM sample collection kit. This new kit enables convenient and safe collection, transportation and handling of pathogenic samples, including COVID-19 and influenza. Two kit configurations are now available: a postal sample kit ideal for home use and a multi-pack of sample kits suitable for on-site mass sampling. To meet growing demand for this sample collection device, EKF has increased its manufacturing capacity in the UK and mainland Europe.

 

Pathogenic samples stored in the FDA-cleared, CE-IVD marked PrimeStore MTM novel viral transport media, including SARS-CoV-2, are inactivated within minutes of collection. This allows such samples to be transported safely through the postal system or via courier and complies with UN3373 packaging regulations. Furthermore, as samples are stable in PrimeStore MTM for seven days at ambient temperatures, this removes the need for all cold chain logistics during sample collection, transportation and storage. Thereby, preventing mishandled samples and making postal collection a realistic option.

 

Multiple nucleic acid species can be tested from one sample as RNA and DNA are perfectly preserved and stabilised by PrimeStore MTM for downstream molecular applications. Furthermore, because PrimeStore MTM totally inactivates SARS-CoV-2, as demonstrated by a recent Public Health England evaluation study, the risk of infection to lab staff from samples is eliminated. This means that samples are not only safe during transportation, but also ready for immediate safe testing at a laboratory with no need for containment.

 

The new sample collection kit pairs PrimeStore molecular transport media in a cryovial with a sterile flocked swab (for nasal and oral sampling) in a CE marked kit, which also includes a UN3373 95kPa compliant specimen collection bag, absorbent pad and instructions for use. In addition, the postal sample collection kit includes a UN3373 compliant postal box with security seal for sample return and postal pouch for collection kit delivery.

                                                                                              

Due to the current COVID-19 pandemic, EKF has received a number of new orders for PrimeStore MTM sample collection devices; including initial orders from two new customers, the Health Service Executive (HSE), Ireland and a national health body in England. These add to the growing demand for PrimeStore MTM from healthcare, education and industry to supply safe sample collection kits for COVID-19 testing programmes.

 

To ensure that it can fulfil the increasing orders for PrimeStore MTM and the new sample collection kit, EKF is ramping up manufacture in the UK and also mainland Europe. The Company has now started production at its facilities in Barleben, Germany, and will soon be moving its current Penarth-based manufacturing lines in Wales to a new larger facility in Llandough, Cardiff, which is over 600 sq. metres in size. This represents a 100% increase in manufacturing area.

 

For more information on EKF Diagnostics, see www.ekfdiagnostics.com.

 

This press release is available online at: https://www.ekfdiagnostics.com/ekf-launches-primestore-mtm-pathogenic-sample-collection-and-transportation-kit.html

 

Related

MRC Technology and Biocartis initiate development of liquid biopsy test for breast cancer

Partnership aimed at the development of molecular diagnostic assays on Biocartis’ fully automated I...

Read More >

Protect Your Samples from Acidification When Shipped On Dry Ice

The new ProtectR® tubes, now available from Alpha Laboratories, have the only container closure syst...

Read More >

Expanding Global IVD Business Exhibits at the World’s Largest Lab Expo

BBI Solutions (BBI), a leading and rapidly expanding manufacturer of raw materials and finished test...

Read More >

BioIVT to Provide Rare Biosamples for the FNIH Biomarkers Consortium Neurodegenerative Disease Project

BioIVT, a leading provider of biospecimens, research models and services for drug and diagnostic dev...

Read More >

SpeeDx Pty. Ltd. establishes US-based operation

SYDNEY, AUSTRALIA–(December 04, 2017). SpeeDx Pty. Ltd, a developer of advanced multiplex molecular...

Read More >